Moderna launches patent dispute with BioNT...For the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement. more ➔
Belgian eTheRNA raises €39m in Series B2...Moderna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a €39m Series B2 financing in eTheRNA. more ➔
Kinarus announces CHF 20 million convertib...Kinarus Therapeutics Holding AG has raised US$20m in financing through the issuance of convertible bonds to YA II PN, Ltd. more ➔
Cancer: Western life style is a killerA study in the scientific journal The Lancet shows that half of all global cancer deaths are due to life style-related risk factors such as smoking and alcohol use. more ➔
Ryvu Therapeutics bags €22m from EIB Polish cancer drug developer, Ryvu Therapeutics, has received €22m funding from the European Investment Bank via its venture debt instrument. more ➔
Largest beer brewer to use sustainable PEF...Avantium and AmBev, part of AB InBev Group, have inked an agreement on PEF for soft drink bottles. more ➔
Vector Biopharma kicks of with CHF30m Seri...With a Series A funding of CHF 30m from Versant Ventures, Vector Biopharma AG set out to solve several of the current gene delivery problems. more ➔
Two deaths with Novartis gene therapySwiss-headquarterd Novartis AG has reported two cases of fatal liver failure after treatment with the gene therapy Zolgensma. more ➔
Azenta set to acquire B Medical SystemsAzenta Inc has entered into an agreement to acquire B Medical Systems S.á r.l. and its subsidiaries for €410m. more ➔
Sartorius pays £415m for Albumedix LtdSartorius Stedim Biotech has purchased the world’s largest human albumin producer Albumedix to broaden its product portfolio in animal-free cell media and to stabilise protein drugs. more ➔
